OncoCyte (OCX) Reports FY Loss of $3.37
OncoCyte (NASDAQ: OCX) reported FY EPS of ($3.37). Revenue for the year came in at $1.5 million.
For earnings history and earnings-related data on OncoCyte (OCX) click here.
OncoCyte (NASDAQ: OCX) reported FY EPS of ($3.37). Revenue for the year came in at $1.5 million.
For earnings history and earnings-related data on OncoCyte (OCX) click here.